Lehrstuhl für Innere Medizin I (Medizin 1)

Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms (2021) Weindl L, Atreya I, Dietrich P, Neubeck S, Neurath M, Pavel ME Journal article Muscle‐derived cytokines reduce growth, viability and migratory activity of pancreatic cancer cells (2021) Schwappacher R, Dieterich W, Reljic D, Pilarsky C, Mukhopadhyay D, Chang DK, Biankin AV, et al. Journal article Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours (2021) Dawod M, Gordoa TA, Cives M, De Mestier L, Crona J, Spada F, Oberg K, et al. Journal article, Review article Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study (2021) Tittel SR, Laubner K, Schmid SM, Kress S, Merger S, Karges W, Wosch FJ, et al. Journal article Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease (2021) Drobny A, Ngo PA, Neurath M, Zunke F, Lopez-Posadas R Journal article, Review article Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy (2021) Bojarski C, Waldner M, Rath T, Schürmann S, Neurath M, Atreya R, Siegmund B Journal article, Review article The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases (2021) Anchang CG, Xu C, Raimondo MG, Atreya R, Maier A, Schett G, Zaburdaev V, et al. Journal article, Review article E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis (2021) Patankar J, Muller TM, Kantham S, Acera MG, Mascia F, Scheibe K, Mahapatro M, et al. Journal article Target heterogeneity in oncology: The best predictor for differential response to radioligand therapy in neuroendocrine tumors and prostate cancer (2021) Puranik AD, Dromain C, Fleshner N, Sathekge M, Pavel ME, Eberhardt N, Zengerling F, et al. Journal article, Review article A randomized trial of a transglutaminase 2 inhibitor for celiac disease (2021) Schuppan D, Mäki M, Lundin KE, Isola J, Friesing-Sosnik T, Taavela J, Popp A, et al. Journal article